Connect with us

Technology

Ceragon Reports 20% Growth in the Fourth Quarter of 2023; Exceeds Full-Year 2023 Guidance

Published

on

Company Guides for Double Digit Growth; Targeting to Further Penetrate Private Network Markets  

ROSH HA’AIN, Israel, Feb. 20, 2024 /PRNewswire/ — Ceragon Networks Ltd. (NASDAQ: CRNT), the global innovator and leading solutions provider of 5G wireless transport, today reported its financial results for the fourth quarter and full year period ended December 31, 2023.

Q4 2023 Financial Highlights:

Revenues of $90.4 million, up 20% year-over-yearSiklu acquisition, which closed on December 4, 2023, contributed modestly to quarterly revenue, in-line with expectationsOperating income of $4.2 million on a GAAP basis, or $7.8 million on a non-GAAP basisNet loss of $(1.2) million on a GAAP basis, and net income of $3.7 million on a non-GAAP basisEPS of $(0.01) per diluted share on a GAAP basis, or $0.04 per diluted share on a non-GAAP basis

FY 2023 Financial Highlights:

Revenues of $347.2 million, up 18% year-over-year, exceeding full-year guidanceCeragon would have achieved the higher-end of its full-year revenue guidance even without contribution from SikluOperating income of $21.2 million on a GAAP basis, or a record $29.0 million on a non-GAAP basisNet income of $6.2 million on a GAAP basis, and $16.7 million on a non-GAAP basisEPS of $0.07 per diluted share on a GAAP basis, or $0.20 per diluted share on a non-GAAP basis

Q4 2023 Business Highlights:

Completed the acquisition of Siklu, expanding presence in North America and augmenting Ceragon’s offering in the Fixed Wireless Access marketNorth America:Continued strong bookings, supported by demand for 5G capabilities from Tier-1 customers and increased footprint with private network customersFourth consecutive quarter of revenues exceeding $20 millionIndia:Continued strong bookings, including initial orders from the approximately $150 million project from global integrator, in support of a network modernization project for a Tier 1 OperatorStrongest region in terms of revenue, with record quarterly revenue since Q2 2018

Doron Arazi, CEO, commented: “Ceragon delivered revenue growth that exceeded our full-year outlook and record full-year non-GAAP operating income. We are encouraged with the recent acquisition of Siklu bolstering our position in the fastest-growing verticals of our market, and continued strong demand for our solutions. In our two key markets, North America and India, we continue to experience strong demand and we remain optimistic that these markets will continue to drive our growth. During 2023, we expanded our presence in the private network market, establishing a scalable foundation for continued growth.”

“We have also reached the point where we can unlock meaningful operating leverage,” continued Arazi. “Our non-GAAP gross margins in the quarter exceeded 35%, and we delivered record levels of annual non-GAAP operating profit. Ceragon has also generated significant full-year free cash flow, enabling us to continue enhancing our product portfolio while growing our profitability.” 

Primary Fourth Quarter 2023 Financial Results:

Revenues were $90.4 million, up 20% from $75.5 million in Q4 2022 and up 3.6% from $87.3 million in Q3 2023.

Gross profit was $31.1 million, giving us a gross margin of 34.4%, compared to gross margin of 32.5% in Q4 2022 and 34.7% in Q3 2023. 

Operating income was $4.2 million compared to $(10.6) million for Q4 2022 and $6.7 million for Q3 2023. The fourth quarter of 2023 included expenses related to the acquisition of Siklu and the consolidation of Siklu results since closing on December 4, 2023. 

Net income (loss) was $(1.2) million, or $(0.01) per diluted share, compared to $(15.0) million, or $(0.18) per diluted share for Q4 2022 and $3.4 million, or $0.04 per diluted share for Q3 2023.

Non-GAAP results were as follows: Gross margin was 35.1%, operating profit was $7.8 million, and net income of $3.7 million, or $0.04 per diluted share. Management continues to expect Siklu to be accretive to non-GAAP earnings by the second-half of 2024. 

Primary Full-Year 2023 unaudited Financial Results:

Revenues were $347.2 million, up 18% from $295.2 million in 2022. 

Gross profit was $119.9 million, giving us a gross margin of 34.5%, compared to a gross margin of 31.5% in 2022. 

Operating income (loss) was $21.2 million compared to $(10.9) million for 2022. 

Net income (loss) was $6.2 million, or $0.07 per diluted share, compared to $(19.7) million, or $(0.23) per diluted share for 2022.

Non-GAAP results were as follows: Gross margin was 34.8%, operating profit was $29.0 million, and net income was $16.7 million, or $0.20 per diluted share.

Balance Sheet

Cash and cash equivalents were $28.2 million at December 31, 2023, compared to $22.9 million at December 31, 2022.

For a reconciliation of GAAP to non-GAAP results, see the attached tables.

Revenue Breakout by Geography:

Q4 2023

India

34 %

North America    

27 %

Latin America    

13 %

Europe     

11 %

Africa    

8 %

APAC   

7 %

Outlook
For 2024, management expects:

Revenue of $385 million to $405 million, representing growth of 11% to 17% compared to 2023 revenue. This guidance includes the contribution from Siklu, which was acquired in December 2023.Non-GAAP operating margins are targeted to be at least 10% at the mid-point of the revenue guidance.As a result, management expects increased non-GAAP profit and positive free cash flow for the full year of 2024.

Conference Call

The Company will host a Zoom web conference today at 8:30 a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. 

Investors are invited to register by clicking here. All relevant information will be sent upon registration. 

If you are unable to join the live call, a replay will be available on our website at www.ceragon.com within 24 hours after the call. 

About Ceragon Networks

Ceragon Networks Ltd. (NASDAQ: CRNT) is the global innovator and leading solutions provider of 5G wireless transport. We help operators and other service providers worldwide increase operational efficiency and enhance end customers’ quality of experience with innovative wireless backhaul and fronthaul solutions. Our customers include service providers, public safety organizations, government agencies and utility companies, which use our solutions to deliver 5G & 4G broadband wireless connectivity, mission-critical multimedia services, stabilized communications, and other applications at high reliability and speed.

Ceragon’s unique multicore technology and disaggregated approach to wireless transport provides highly reliable, fast to deploy, high-capacity wireless transport for 5G and 4G networks with minimal use of spectrum, power, real estate, and labor resources. It enables increased productivity, as well as simple and quick network modernization, positioning Ceragon as a leading solutions provider for the 5G era. We deliver a complete portfolio of turnkey end-to-end AI-based managed and professional services that ensure efficient network rollout and optimization to achieve the highest value for our customers. Our solutions are deployed by more than 400 service providers, as well as more than 800 private network owners, in more than 150 countries. For more information please visit: www.ceragon.com.

Ceragon Networks® and FibeAir® are registered trademarks of Ceragon Networks Ltd. in the United States and other countries. CERAGON ® is a trademark of Ceragon Networks Ltd., registered in various countries. Other names mentioned are owned by their respective holders.

Safe Harbor

This press release contains statements that constitute “forward-looking statements” within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended, and the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the current beliefs, expectations and assumptions of Ceragon’s management about Ceragon’s business, financial condition, results of operations, micro and macro market trends and other issues addressed or reflected therein. Examples of forward-looking statements include, but are not limited to, statements regarding: projections of demand, revenues, net income, gross margin, capital expenditures and liquidity, competitive pressures, order timing, supply chain and shipping, components availability; growth prospects, product development, financial resources, cost savings and other financial and market matters. You may identify these and other forward-looking statements by the use of words such as “may”, “plans”, “anticipates”, “believes”, “estimates”, “targets”, “expects”, “intends”, “potential” or the negative of such terms, or other comparable terminology, although not all forward-looking statements contain these identifying words.

Although we believe that the projections reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations therefrom will not be material. Such forward-looking statements involve known and unknown risks and uncertainties that may cause Ceragon’s future results or performance to differ materially from those anticipated, expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the effects of global economic trends, including recession, rising inflation, rising interest rates, commodity price increases and fluctuations, commodity shortages and exposure to economic slowdown; The effects of the evolving nature of the war situation in Israel, including in Gaza with the Hamas and in Lebanon with the Hezbollah and the related evolving regional conflict, including without limitation, the Houti attacks on marine vessels; risks associated with delays in the transition to 5G technologies and in the 5G rollout; the risks associated with the introduction of new products to the market, including but not limited to potential delays, unexpected costs, regulatory hurdles and potential technical flaws; risks relating to the concentration of our business on a limited number of large mobile operators and the fact that the significant weight of their ordering, compared to the overall ordering by other customers, coupled with inconsistent ordering patterns, could negatively affect us; risks resulting from the volatility in our revenues, margins and working capital needs; disagreements with tax authorities regarding tax positions that we have taken could result in increased tax liabilities;  the high volatility in the supply needs of our customers, which from time to time lead to delivery issues and may lead to us being unable to timely fulfill our customer commitments; risks associated with inaccurate forecasts or business changes, which may expose us to inventory-related losses on inventory purchased by our contract manufacturers and other suppliers, to increased expenses should unexpected production ramp up be required, or to write off to parts of our inventory, which would increase our cost of revenues; potential adverse reactions or changes to business relationships resulting from the completion of the transaction with Siklu, and ongoing or potential litigations or disputes, incidental to the conduct of Siklu’s business and other risks related to the integration of Siklu’s business into Ceragon business; disagreements with tax authorities regarding tax positions that we have taken could result in increased tax liabilities and such other risks, uncertainties and other factors that could affect our results of operation, as further detailed in Ceragon’s most recent Annual Report on Form 20-F, as published on May 1, 2023, as well as other documents that may be subsequently filed by Ceragon from time to time with the SEC. 

We caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Ceragon does not assume any obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release unless required by law.

While we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. In addition, any forward-looking statements represent Ceragon’s views only as of the date of this press release and should not be relied upon as representing its views as of any subsequent date. Ceragon does not assume any obligation to update any forward-looking statements unless required by law.

The results reported in this press-release are preliminary and unaudited results, and investors should be aware of possible discrepancies between these results and the audited results to be reported, due to various factors.

Ceragon’s public filings are available on the Securities and Exchange Commission’s website at www.sec.gov and may also be obtained from Ceragon’s website at www.ceragon.com

Ceragon Investor & Media Contact:

Rob Fink 
FNK IR
Tel. 1+646-809-4048
crnt@fnkir.com 

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, U.S. dollars in thousands, except share and per share data)

(Unaudited)

Three months ended

December 31,

Year ended

December 31,

2023

2022

2023

2022

Revenues

$     90,359

$    75,531

$  347,179

$  295,173

Cost of revenues

59,296

50,999

227,310

202,110

Gross profit

31,063

24,532

119,869

93,063

Operating expenses:

Research and development, net

9,070

8,080

32,274

29,690

Sales and Marketing

10,544

8,998

40,577

35,795

General and administrative

6,445

17,826

23,793

34,295

Restructuring and related charges

897

Acquisition and integration-related charges

835

1,118

Other operating expenses (*)

249

4,220

Total operating expenses

26,894

35,153

98,659

104,000

Operating income (loss)

4,169

(10,621)

21,210

(10,937)

Financial expenses and others, net

3,402

3,012

8,468

6,306

Income (loss) before taxes

767

(13,633)

12,742

(17,243)

Taxes on income

1,970

1,385

6,522

2,446

Net income (loss)

$     (1,203)

$   (15,018)

$      6,220

$   (19,689)

Basic net income (loss) per share

$       (0.01)

$       (0.18)

$        0.07

$       (0.23)

Weighted average number of shares used in computing  basic net income (loss) per share

85,054,173

84,347,548

84,617,774

84,132,982

Diluted net income (loss) per share

$       (0.01)

$       (0.18)

$        0.07

$       (0.23)

Weighted average number of shares used in computing diluted net income (loss) per share

85,054,173

84,347,548

85,482,626

84,132,982

(*) Hostile attempt related costs.

                                  

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands)

December 31,

2023

December 31,

2022

ASSETS

Unaudited

Audited

CURRENT ASSETS:

Cash and cash equivalents

$            28,237

$           22,948

Trade receivables, net

104,321

100,034

Other accounts receivable and prepaid expenses

16,571

15,756

Inventories

68,811

72,009

Total current assets

217,940

210,747

NON-CURRENT ASSETS:

   Severance pay and pension fund

4,985

4,633

   Property and equipment, net

30,659

29,456

   Operating lease right-of-use assets

18,837

17,962

   Intangible assets, net

16,401

8,208

   Goodwill

7,749

    Other non-current assets

1,954

18,312

Total non-current assets

80,585

78,571

Total assets

$         298,525

$         289,318

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES:

Trade payables

67,032

67,384

Deferred revenues

5,507

3,343

Short-term loans

32,600

37,500

Operating lease liabilities

3,889

3,745

Other accounts payable and accrued expenses

23,925

20,864

Total current liabilities

132,953

132,836

LONG-TERM LIABILITIES:

Accrued severance pay and pension

9,399

9,314

Deferred revenues

670

11,545

Other long-term payables

7,768

2,653

Operating lease liabilities

13,716

13,187

Total long-term liabilities

31,553

36,699

SHAREHOLDERS’ EQUITY:

Share capital:

     Ordinary shares

222

224

Additional paid-in capital

437,161

432,214

Treasury shares at cost

(20,091)

(20,091)

Other comprehensive loss

(8,085)

(11,156)

Accumulated deficit

(275,188)

(281,408)

Total shareholders’ equity

134,019

119,783

Total liabilities and shareholders’ equity

$        298,525

$          289,318

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited, U.S. dollars, in thousands)

(Unaudited)

Three months ended

December 31,

Year ended

December 31,

2023

2022

2023

2022

Cash flow from operating activities:

Net income (loss)

$       (1,203)

$      (15,018)

$        6,220

$     (19,689)

Adjustments to reconcile net income (loss) to net cash
  provided by (used in) operating activities:

Depreciation and amortization

2,466

2,622

9,967

11,040

Loss from sale of property and equipment, net

61

20

Stock-based compensation expense

938

958

3,964

3,560

Increase (decrease) in accrued severance pay and pensions, net

88

245

(267)

(445)

Decrease (increase) in trade receivables, net

1,856

15,942

(2,370)

18,428

Decrease (increase) in other accounts receivable and prepaid
  expenses (including other long term assets)

15,085

1,414

16,994

(345)

Decrease (increase) in inventory

4,681

(7,845)

6,303

(11,155)

Decrease in operating lease right-of-use assets

794

845

3,781

3,571

Increase in trade payables

(1,121)

(5,191)

(1,847)

(2,018)

Increase (decrease) in other accounts payable and accrued
  expenses (including other long term liabilities)

(2,720)

(2,190)

1,677

(4,154)

Decrease in operating lease liability

(73)

(779)

(4,034)

(5,937)

Increase (decrease) in deferred revenues

(9,830)

494

(9,562)

2,229

Net cash provided by (used in) operating activities

$      10,961

$        (8,503)

$       30,887

$      (4,895)

Cash flow from investing activities:

Purchases of property and equipment, net

(2,548)

(1,432)

(9,955)

(10,464)

Purchases of intangible assets

(661)

(697)

(2,944)

(1,957)

Payments made in connection with business acquisitions, net
  of acquired cash

(7,971)

(7,971)

Net cash used in investing activities

$      (11,180)

$          (2,129)

$     (20,870)

$     (12,421)

Cash flow from financing activities:

Proceeds from exercise of options

9

39

410

Proceeds from (repayments of) bank credits and loans, net

(5,600)

7,600

(4,900)

22,700

Net cash provided by (used in) financing activities

$        (5,591)

$           7,600

$        (4,861)

$      23,110

Translation adjustments on cash and cash equivalents

$              81

$                16

$            133

$             75

Increase (decrease) in cash and cash equivalents

$        (5,729)

$          (3,016)

$         5,289

$        5,869

Cash and cash equivalents at the beginning of the period

33,966

25,964

22,948

17,079

Cash and cash equivalents at the end of the period

$        28,237

$          22,948

$        28,237

$      22,948

 

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS

(U.S. dollars in thousands, except share and per share data

(Unaudited)

Three months ended

         Year ended

December 31,

December 31,

2023

2022

2023

2022

GAAP cost of revenues

$

59,296

$

50,999

$

227,310

$

202,110

Stock-based compensation expenses

(115)

(169)

(482)

(587)

Changes in indirect tax positions

(279)

(3)

(281)

Amortization of acquired intangible assets

(57)

(57)

Excess cost on acquired inventory in business combination*

(525)

(525)

Non-GAAP cost of revenues

$

58,599

$

50,551

$

226,243

$

201,242

GAAP gross profit

$

31,063

$

24,532

$

119,869

$

93,063

Stock-based compensation expenses

115

169

482

587

Changes in indirect tax positions

279

3

281

Amortization of acquired intangible assets

57

57

Excess cost on acquired inventory in business combination

525

525

Non-GAAP gross profit

$

31,760

$

24,980

$

120,936

$

93,931

GAAP Research and development expenses

$

9,070

$

8,080

$

32,274

$

29,690

Stock-based compensation expenses

(156)

(217)

(828)

(405)

Loss from termination of joint development agreement

(1,199)

(1,199)

Non-GAAP Research and development expenses

$

7,715

$

7,863

$

30,247

$

29,285

GAAP Sales and Marketing expenses

$

10,544

$

8,998

$

40,577

$

35,795

Stock-based compensation expenses

(320)

(393)

(1,416)

(1,355)

Amortization of acquired intangible assets

(49)

(49)

Non-GAAP Sales and Marketing expenses

$

10,175

$

8,605

$

39,112

$

34,440

GAAP General and Administrative expenses

$

6,445

$

17,826

$

23,793

$

34,295

Stock-based compensation expenses

(347)

(179)

(1,238)

(1,213)

Retired CEO compensation

96

Non-GAAP General and Administrative expenses

$

6,098

$

17,647

$

22,555

$

33,178

GAAP Restructuring and related charges

$

$

$

897

$

Restructuring and related charges

(897)

Non-GAAP restructuring and related charges

$

$             –

$               –

$               –

GAAP Acquisition and integration-related charges

$

835

$

$

1,118

$

Acquisition and integration-related

(835)

(1,118)

Non-GAAP acquisition and integration-related charges

$

$             –

$               –

$               –

GAAP Other operating expenses

$

$

249

$

$

4,220

Hostile attempt related costs

(249)

(4,220)

Non-GAAP other operating expenses

$

$             –

$               –

$               –

 

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS

(U.S. dollars in thousands, except share and per share data

(Unaudited)

Three months ended

Year Ended

December 31,

December 31,

2023

2022

2023

2022

GAAP operating income (loss)                        

$

4,169

$

(10,621)

$

21,210

$

(10,937)

Stock-based compensation expenses

938

958

3,964

3,560

Changes in indirect tax positions

279

3

281

Amortization of acquired intangible assets

106

106

Excess cost on acquired inventory in business combination*

525

525

Loss from termination of joint development agreement

1,199

1,199

Retired CEO compensation

(96)

Hostile attempt related costs

249

4,220

Restructuring and other charges

897

Acquisition and integration-related charges

835

1,118

Non-GAAP operating income (loss)

$

7,772

$

(9,135)

$

29,022

$

(2,972)

GAAP financial expenses and others, net

$

3,402

$

3,012

$

8,468

$

6,306

Non-cash revaluation associated with acquisition

(110)

(110)

Leases – financial income (expenses)

(754)

(154)

253

2,278

Non-GAAP financial expenses & others, net

$

2,538

$

2,858

$

8,611

$

8,584

GAAP Tax expenses

$

1,970

$

1,385

$

6,522

$

2,446

Noncash tax adjustments

(478)

(851)

(2,851)

(1,278)

Non-GAAP Tax expenses

$

1,492

$

534

$

3,671

$

1,168

 

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS

(U.S. dollars in thousands, except share and per share data

(Unaudited)

Three months ended

Year Ended

December 31,

December 31,

2023

2022

2023

2022

GAAP net income (loss)

$

(1,203)

$

(15,018)

$

6,220

$

(19,689)

Stock-based compensation expenses

938

958

3,964

3,560

Changes in indirect tax positions

279

3

281

Amortization of acquired intangible assets

106

106

Excess cost on acquired inventory in business combination*

525

525

Loss from termination of joint development agreement

1,199

1,199

Retired CEO compensation

(96)

Hostile attempt related costs

249

4,220

Restructuring and other charges

897

Acquisition and integration-related charges

835

1,118

Non-cash revaluation associated with acquisition

110

110

Non-cash tax adjustments

478

851

2,851

1,278

Leases – financial income (expenses)

754

154

(253)

(2,278)

Non-GAAP net income (loss) 

$

3,742

$

(12,527)

$

16,740

$

(12,724)

GAAP Basic net income (loss) per share

$

(0.01)

$

(0.18)

$

0.07

$

(0.23)

GAAP Diluted net income (loss) per share

$

(0.01)

$

(0.18)

$

0.07

$

(0.23)

Non GAAP Diluted net income (loss) per share (**)

$

0.04

$

(0.15)

$

0.20

$

(0.15)

(*) Consists of charges to cost of revenues for the difference between the fair value of acquired inventory in business combination, which was recorded at fair value, and the actual cost of this inventory, which impacts the Company’s gross profit.
(**) Weighted average number of shares used in computing diluted net income (loss) per share is the same as in GAAP

Logo: https://mma.prnewswire.com/media/1704355/Ceragon_Networks_Ltd_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/ceragon-reports-20-growth-in-the-fourth-quarter-of-2023-exceeds-full-year-2023-guidance-302066012.html

SOURCE Ceragon Networks Ltd.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ASUS Accelerates Enterprise AI at Scale with 6th-Gen AMD EPYC Server CPUs

Published

on

By

 ASUS leverages 6th-gen AMD EPYC Server CPUs to deliver scalable, efficient compute for enterprise AI, cloud, virtualization and business-critical workloads

SAN FRANCISCO, July 24, 2026 /PRNewswire/ — ASUS today announced its groundbreaking new server lineup powered by the AMD EPYC™ 9006 processors, engineered to deliver unmatched performance for the most demanding intensive enterprise workloads. This advanced portfolio introduces two highly optimized series with efficiency-optimized AMD EPYC SP8 server CPU, the flagship dual-socket ASUS RS700A/720A for extreme compute density and the single-socket ASUS RS500A/520A for superior space efficiency and deployment flexibility.

Both series integrate full PCIe® 6.0, leading memory support, and high-density E3.S storage, all underpinned by proprietary ASUS innovations for superior thermal management and operational efficiency to meet and exceed the rigorous demands of enterprise AI, virtualization, storage and cloud environments.

“The new ASUS server series, powered by 6th-gen AMD EPYC server CPUs, is engineered to power every enterprise workload with flexible, scalable infrastructure,” Paul Ju, Senior Vice President of ASUS, commented, “This launch marks a significant milestone for ASUS and our clients. The new series empowers businesses with a resilient foundation to achieve unprecedented computing efficiency and accelerating AI innovation with inference.”

ASUS expands 6th-gen AMD EPYC server portfolio with dual optimized series

ASUS has introduced a new server lineup segmented into two distinct series, each precisely engineered to meet diverse enterprise demands.

The flagship RS700A/720A series (dual-socket) delivers extreme compute density, making it ideal for AI inferencing, and complex simulations. It offers exceptional bandwidth with PCIe 6.0, memory leadership via 32 DIMM slots supporting ultrafast MRDIMM, and high-density storage with up to 32 E3.S bays in a compact 2U form factor.

Complementing this is the RS500A/520A series (single-socket), a highly efficient and space-optimized solution with depth under 800mm, perfect for mainstream enterprise workloads and rack-constrained environments. Featuring full PCIe 6.0 capabilities, E3.S storage support, and modular scalability through shared components with the RS700A and RS720A series, it provides uncompromised performance in a streamlined, deployment-friendly design.

ASUS elevates the AMD EPYC platform with cutting-edge proprietary innovations

ASUS has significantly advanced the AMD EPYC 9006 platform with a series of proprietary engineering breakthroughs focused on superior reliability, thermal management, and operational efficiency.

The DC-MHS modular architecture features a zone-partitioned chassis that separates I/O, HPM, fan, and storage modules to accelerate development, reduce capital costs, and enable rapid serviceability. The patented ASUS DIMM.2 Innovation repositions M.2 storage to the cooler DIMM region, eliminating thermal throttling without extra heatsinks and unlocking greater scalability. Thermal Radar 3.0 with PID Control delivers precise real-time fan regulation via advanced algorithms, reducing energy use and maintaining peak performance under heavy enterprise-level workload.

Completing the suite is the optimized tool-less operational-velocity design, which boosts maintenance efficiency, maximizing uptime and lowering TCO and sustaining peak performance even under volatile, high-load AI/HPC workloads.

AVAILABILITY & PRICING

ASUS RS700A/720A series and RS500A/520A series servers will be available soon. Please contact your local ASUS representative for further information.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/asus-accelerates-enterprise-ai-at-scale-with-6th-gen-amd-epyc-server-cpus-302833931.html

Continue Reading

Technology

Fractal posts 20% revenue growth and 92% net income growth in Q1 FY27

Published

on

By

Adjusted EBITDA Grows at 35% YoYGross Margin up 29 bps1 to 46%; Adjusted EBITDA Margin up 189 bps to 17%

NEW YORK, July 24, 2026 /PRNewswire/ — Fractal Analytics Ltd (BSE: 544700) (NSE: FRACTAL) announced its consolidated financial results for Q1 FY27, ending June 30, 2026.

In Q1 FY27, the Company reported consolidated operating revenue of INR 9,125 m, a growth of 20% year on year (YoY). Revenue growth was led by the company’s Healthcare and Life Sciences (HLS) industry, which clocked 69% growth YoY. Strong sustained growth in HLS over the last several quarters has resulted in it becoming the second largest industry in the portfolio. Banking, Financial Services and Insurance (BFSI) also performed very well, growing 36% YoY in Q1. Fractal’s largest industry, Consumer Packaged Goods and Retail (CPGR), continued to gather momentum, growing 19% YoY. On the other hand, TMT declined 22% YoY.

Fractal’s focus on deepening customer relationships continues to yield good outcomes. Its clients collectively increased their spending with the company, as reflected in the Net Revenue Retention2 of 117% in Q1. Further, its Net Promoter Score (NPS) during the period stood at 77.

The company reported improved profit margins at all levels. Gross Margin in Q1 was at 46%, while Adjusted EBITDA Margin expanded by 189 bps YoY to 17%. Net Income grew 92% YoY to INR 723 m.

Commenting on the performance, Srikanth Velamakanni, Group CEO and Executive Vice-Chairman, said:

“Enterprises are putting real transformation budgets behind AI now and we’re seeing it directly in the size of the deals coming to us. TMT was the drag on our headline growth this quarter. Excluding TMT, our business grew 35% year on year, which is a better read on the underlying demand we’re seeing.

As data sovereignty becomes a bigger priority for governments and enterprises, and as open-weight models keep improving, clients need a partner who can work across models and infrastructure. We have invested heavily in our people, our research, and our own intellectual property to be that partner.”

1 Basis points = 1/100th of 1%
2 Net Revenue Retention in our Fractal.ai segment measures how effectively we retain and expand revenue from our existing clients over a defined period and is calculated by comparing the current period’s revenue from the clients who existed at the start of the period, with their revenue in the previous period – including the effects of upsells, cross-sells and contractions

About Fractal 

Fractal Analytics Ltd (BSE: 544700) (NSE: FRACTAL) is a globally recognized pure-play enterprise AI company trusted by Fortune 500®-sized enterprises to power decision-making through AI services, solutions, and products, anchored by Cogentiq, its flagship agentic AI platform. With over 6,000 professionals across North America, EMEA, and Asia-Pacific, Fractal partners with business leaders to drive competitive differentiation for their organizations by embedding AI into critical decisions across business functions and industry verticals.

Fractal invests more than 6% of its revenue in AI R&D, supporting foundational AI research, product development, and IP creation that address both immediate client needs and long-term technological advancement. Fractal’s track record includes developing proprietary models and products such as Cogentiq Health – Vaidya.ai and Cogentiq Data Science – PiEvolve, as well as incubating and spinning out Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal’s suite of businesses consists of Asper.ai (a Revenue Growth Management product for CPG companies) and Analytics Vidhya (an Ed-tech platform).

For more information, go to www.fractal.ai.

Logo: https://mma.prnewswire.com/media/2931510/5858548/Fractal_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/fractal-posts-20-revenue-growth-and-92-net-income-growth-in-q1-fy27-302833932.html

SOURCE Fractal Analytics Limited

Continue Reading

Technology

Xryma Plc : Pre-Listing Liquidity Facility and Price Discovery Process

Published

on

By

NICOSIA, Cyprus, July 24, 2026 /PRNewswire/ — Xryma Plc (“Xryma”)  announces its intention to reapply within the next twelve months for admission to list on Euronext Paris (“Euronext”), with such admission being subject to Euronext’s approval. Before submitting its application, Xryma intends to launch a pre-listing liquidity facility and price discovery process, comprising a private placement to institutional and qualified investors alongside a secondary market offer to Xryma existing shareholders (“shareholders”) wishing to exit prior to listing.  

The admission referred to above that is subject to the approval of Euronext may also be subject to approval by relevant regulatory authorities, and no assurance can be given that approval will be granted or as to the timing of any admission.

The pre-listing liquidity facility and price discovery process is designed to:

Enable shareholders seeking an exit to participate without the need to open an EU brokerage account,Provide a clear and orderly opportunity for existing shareholders to sell all or part of their holdings ahead of any potential admission to trading on Euronext Paris,Enable shareholders to sell all or part of their holdings at the same price at which qualified and institutional investors subscribe for shares in the Company,Establish, through a bookbuild with qualified and institutional investors, a market-validated referenced price for Xryma shares ahead of any potential admission on Euronext Paris (the “Primary Market Placement Price”),Support orderly trading upon potential admission.

Individual shareholder mailouts explaining the details of the pre-listing liquidity facility scheme with instructions and necessary documentation will be conducted during August 2026.

As the Primary Market Placement Price is to be determined by the subsequent bookbuild, shareholders will be given the opportunity to set a floor price which will result in the sale of their shares if the Primary Market Placement Price is higher.  Shareholders will receive the Primary Market Placement Price minus applicable fees.

Shareholders and Investors may be scaled back to match corresponding demand from the other party, with partial fulfilment a possibility if the Company cannot match supply to demand.

Completion of the process is subject to achieving a level of institutional and qualified investor demand that the Board considers appropriate to support an orderly market should Xryma subsequently be admitted to trading on Euronext Paris.

Participation is entirely voluntary. Shareholders who do not wish to sell will simply retain their shares. Shareholders that do not intend to participate should continue to onboard with a Euronext participating broker, or a Euroclear ESES custodian, per previous communications.

The major shareholders, SCP Select All Enterprise (Monaco) and SCP Red 5 Solutions (Monaco) will not participate in the offer and will be subject to lock up arrangements.

Mr Nikogiannis (John) Karantzis, CEO of Xryma Plc comments: “Our shareholders have told us they would value a straightforward way to realise their holdings without the time and cost of opening an EU brokerage account. This process is our response to that feedback. We are structuring the placement to be large enough to establish a credible reference price whilst limiting dilution, with demand directed first towards meeting shareholder sell interest. We look forward to updating the market on the revised timetable in due course.”

Shareholders seeking a more detailed explanation of the pre-listing liquidity facility and price discovery process, should refer to the guide available at https://www.xryma.com/investors

Important Information & Disclaimers

This press release may contain inside information within the meaning of Article 7(1) of Regulation (EU) 596/2014 (Market Abuse Regulation).

This publication is not for publication or distribution or release, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States and the District of Columbia), Canada, Australia, South Africa, Japan or any other jurisdiction where such an announcement would be unlawful. The distribution of this publication may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. No action has been taken that would permit an offering of the treasury shares or possession or distribution of this publication in any jurisdiction where action for that purpose is required.

This publication does not constitute or form part of an offer for sale or solicitation of an offer to purchase or subscribe for securities in the United States, Canada, Australia, South Africa, Japan or any other jurisdiction and the securities referred to herein have not been registered under the securities laws of any such jurisdiction. Any New Shares (if such are issued) will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”), or under the securities laws of any State or any other jurisdiction of the United States, and may not be offered or sold, directly or indirectly, in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of, the Securities Act and in compliance with all applicable securities laws of any State or any other jurisdiction of the United States. No public offering of securities is being made in the United States or in any other jurisdiction.

The information set forth herein must not be distributed in any jurisdiction where such distribution is unlawful, and any recipients are requested to inform themselves about and to observe such restrictions.

The Offering referred to herein by Xryma Plc will only be made in accordance with all applicable corporate and securities laws. Any shares referred to herein will exclusively be offered or sold in reliance on any applicable exemptions from prospectus or registration requirements in any jurisdiction. In member states of the European Economic Area, this publication is only addressed to and directed at persons who are ‘qualified investors’ within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended and including any relevant delegated regulations, the “Prospectus Regulation”) or in any other circumstances falling within exemptions available in the relevant member state under Article 1(4) and/or 1(5) of the Prospectus Regulation. In the United Kingdom, this publication is only addressed to and directed at qualified investors within the meaning of the Prospectus Regulation, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended (“EUWA”), who are persons (i) who have professional experience in matters relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (ii) falling within article 49(2)(a) to (d) (high net worth companies, incorporated associations, etc.) of the Order, or (iii) to whom it may otherwise be lawfully communicated; any other persons in the United Kingdom should not take any action on the basis of this publication and should not act on or rely on it.

This publication does not constitute a recommendation concerning the prospective Offering. This announcement does not constitute an Offer or invitation to subscribe.

This announcement includes statements that are, or may be deemed to be, ‘forward looking statements’. These forward-looking statements can be identified by the use of forward looking terminology, including the terms ‘believes’, ‘estimates’, ‘anticipates’, ‘expects’, ‘intends’, ‘may’, ‘will’, or ‘should’ or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. By their nature, forward looking statements involve risk and uncertainty because they relate to future events and circumstances which may or may not occur. Many of these factors are beyond the control of the Company. Should one or more of these risks or uncertainties materialise, or should underlying assumptions prove incorrect, actual results and circumstances may vary materially from those described in this announcement as anticipated, believed, estimated or expected.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/xryma-plc–pre-listing-liquidity-facility-and-price-discovery-process-302833658.html

Continue Reading

Trending